Katherine A. Eade
CIK: 0001721318
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HBIO
HARVARD BIOSCIENCE INC
Director
Discretionary Trading P&L
Holdings
About Eade Katherine A.
Eade Katherine A. (SEC CIK 0001721318) files insider reports with the SEC as Director of HARVARD BIOSCIENCE INC (HBIO).
Signal8 holds 2 ownership filings by Eade Katherine A., all Form 4s, filed between Jul 18, 2025 and Jun 12, 2026. Those filings report 2 transactions, from Jul 16, 2025 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Eade Katherine A.'s filings is in HOLLISTON, MA.
Recent filings by Eade Katherine A.
Other insiders filing for HARVARD BIOSCIENCE INC (HBIO)
- Snider William, Director
- DENELSKY STEPHEN J, Director
- Gagnon Robert E., Director
- Benson Seth Benjamin, Director
- Frost Mark T, Chief Financial Officer
- Duke John D, Chief Executive Officer